CataloniaBio & HealthTech and EY will present the Study on investment in the Biomedical industry in Catalonia 2019 on 16 May at the Cercle d’Economia auditorium.

Published annually since 2017, this study compiles the main indicators and offers an analysis of business investment in the Catalan biomedical ecosystem in order to valorise it and make it more attractive to international investors, companies and talent.

10:00 am     Accreditations

10:15 am     Presentation of study
                    Jaume Amat, president of CataloniaBio & HealthTech and CEO of Specipig
                    Silvia Ondategui, managing partner of the EY Life Sciences division

10:45 am     Panel discussion "A sector with collaboration in its blood: key to success"
                    Fina Lladós, CEO of Amgen Iberia
                    Sara Secall, Investment Director of Inveready
                    Montserrat Barceló, Board Member of Kymos Pharma
                    Moderator: Jordi Naval, CEO of Biocat

11:15 am     Question time

11:30 am     Closing

For CataloniaBio & HealthTech members and by invitation only. Please confirm attendance.

After the event, the digital version of the study will be available in the “Publications” section of this website. 

On Twitter #InversióCataloniaBioHT

Related news:

• Report: "Catalan biomedical companies attracted €106 million in investment in 2018"
• Photo gallery
• Download the study (PDF)